Motolimod
N/A
Report date: 2023/02/25 20:00:34
NME
Base Information
Drug NameMotolimod
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[33]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesArray BiopharmaCelgene Corp
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesBristol Myers Squibb SrlcompanyNational Cancer InstitutePresage Biosciences Inc +[5]
Active IndicationsN/A
Inactive Indications +[33]
Other Information
ATC CodeN/A
Related LinksKEGG